OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Review how neo-adjuvant therapy impacted breast surgery decisions in the past
2. Demonstrate how neo-adjuvant therapy impacts breast surgery decisions in the present
3. Evaluate how neo-adjuvant therapy will impact breast surgery decisions in the future

FACULTY DISCLOSURE: Michael Berry, MD, has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

FACULTY DISCLOSURE: Michael Berry, MD, was on the speakers’ bureau for Astra Zeneca.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Monique Hassan, MD is a speaker for Intuitive Surgical, and Boehringer and was a speaker for Medtronic.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC:  Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

MEETIN LINK: